The most common fundraising mistake isn't a bad pitch deck. It's a business that hasn't yet given investors a reason to say yes.
In a previous article, I introduced the fundability gap — the structural distance between operating strength and investor confidence. The most substantive feedback that the article received is worth taking seriously: narrative alone cannot close the gap for revenue-generating companies. In simple terms, investors need to see not just growth, but proof that the growth is repeatable, explainable, durable — and economically viable. For most companies — particularly at the growth and late stages — the dominant reason they struggle to raise is not that investors can’t understand the business. It is that they haven’t yet been given sufficient reason to believe it. The fundability bridge is the answer to that challenge — an operational discipline that turns execution into evidence investors can confidently underwrite, without requiring a founder in the room to explain it.
Why Narrative Alone Fails
Investor skepticism is not primarily a comprehension problem. It is a credibility problem. The contrast between Theranos and Moderna makes this precise. Theranos, a blood-testing diagnostics startup, had one of the most compelling investor narratives in Silicon Valley history — a charismatic founder, a vast addressable market, and technology that promised to democratize diagnostics. Investors believed the story before the execution had been proven, because the narrative was constructed to substitute for proof. The SEC ultimately charged the company with fraud, and the gap between what had been claimed and what had been built proved unbridgeable. Moderna, an mRNA biopharmaceutical company, by contrast, spent years developing a platform that many investors found difficult to underwrite — until the execution produced undeniable, reproducible evidence. When Moderna went public in 2018, the narrative hadn’t fundamentally changed. The body of evidence had become materially harder to dismiss.
The question investors are really asking is not ‘Do I understand this business?’ It is ‘Has this business earned the right to be believed—and underwritten?’
What Investor-Legible Execution Actually Means
Most founders and CEOs track metrics through an internal lens — are we growing, are we hitting targets? Investors read the same metrics differently. They are looking for signals that answer one underlying question: will this growth reliably compound? Execution becomes investor-legible when it demonstrates four characteristics. Repeatability: growth that happens across multiple customers and channels without founder dependency. Causality: the ability to show why growth is happening, not just that it is. Durability: evidence that growth is sticking — cohort retention, net revenue retention, and expansion revenue are the language of durability. Legibility: the degree to which all three can be read clearly by an outside evaluator without a guided tour. The goal is not to simplify the business. It is to present it in the sequence investors use to evaluate it.
The Investor Evidence Chain
The most fundable companies don’t present a collection of metrics. They present a connected chain of evidence that demonstrates the model is economically viable and operationally repeatable: cohort retention (the percentage of customers or revenue that remains active over time) proves the product delivers sustained value; the LTV/CAC ratio (lifetime customer value relative to the cost of acquiring that customer) proves the unit economics of customer acquisition are sound; payback period proves the business isn’t burning capital indefinitely to sustain growth; expansion motion proves the revenue model scales within the existing customer base; and revenue repeatability proves it is the system — not the founder, not a one-time channel — that is driving results. When these metrics are tracked and reported consistently, they become the infrastructure of investor conviction rather than a set of numbers assembled for a pitch.
There is a sixth link that sits beneath all five — and that investors evaluate before the metrics conversation begins: team credibility. Prior company-building experience, relevant domain expertise, and the reputational weight of key hires or advisors function as foundational evidence in every investor conversation. In many institutional and venture contexts, this is not a supporting factor — it is a precondition. A team that has navigated scale, delivered outcomes, and built companies before brings a form of proof that no financial metric can fully substitute for. There is also a network dimension: the ability to access the right investors — through warm introductions, trusted intermediaries, and earned reputational gravity — is itself part of the fundability equation. A company that has built a strong evidence chain but has no pathway into the right rooms faces a gap that operational preparation alone does not close.
Klaviyo, an email and SMS marketing platform for e-commerce businesses, made each link in this chain legible in its S-1 filing: high net revenue retention, low customer acquisition costs through a product-led growth motion, strong payback periods, and documented account expansion. Every link reinforced the next, and Klaviyo went public in 2023 with a market capitalization of over $9 billion. Convoy, a digital freight marketplace, had real revenue and a compelling market narrative, but the evidence chain was incomplete. When the freight recession tightened capital markets, the underlying vulnerability was already present: the growth model hadn’t produced a connected sequence of proof that could withstand scrutiny under economic pressure. The freight recession accelerated the failure, but the downturn exposed weaknesses that the business model was not positioned to absorb.
Investors are not evaluating metrics. They are evaluating whether the chain of evidence holds — and whether it holds without the founder or CEO in the room to explain it.
Where the Bridge Breaks
Most companies that fail to close the fundability gap don’t fail because their execution is weak. They fail because there is a break in the connection between execution and narrative. Three breaks appear consistently. The first is proof that exists internally but isn’t visible externally — the unit economics work, but haven’t been organized into a sequence that an investor can evaluate without help. The fix is not better storytelling. It is building the reporting infrastructure that produces investor-legible outputs as a natural byproduct of running the business.
The second break is a narrative that runs ahead of proof. WeWork, a coworking space company, filed its S-1 in 2019 with a story about transforming how the world works — a narrative so disconnected from the underlying real estate economics that institutional investors quickly challenged whether the underlying economics were viable enough to support the narrative, and the IPO was ultimately withdrawn. The business had real revenue. The evidence chain had no connection to the unit economics behind it. Investors respect epistemic honesty more than founders and CEOs realize: being precise about what has been proven, and what remains to be validated, builds more credibility than an ambitious vision the execution hasn’t yet earned.
The third break is execution that is real but not yet repeatable — customers closed through founder and CEO relationships, a favorable market window, or a one-time channel. This produces traction that looks fundable and isn’t. The fix requires building the repeatable system before entering a fundraising process, not describing it as though it already exists.
Building the Bridge: Four Operational Practices
The fundability bridge isn’t built in a data room. It is built in the eighteen months before you enter one.
Instrument your operations for investor legibility.
Track internally the same metrics investors will ask for externally: cohort retention by quarter, LTV/CAC by channel, payback period by segment, and expansion revenue as a percentage of total ARR (annual recurring revenue). When these become standard internal reporting, they stop requiring translation at the moment of fundraising.
Separate what is proven from what is projected.
Build a clear internal distinction between what execution has demonstrated and what strategy anticipates. The companies that earn investor belief fastest can say precisely: here is what we have proven, here is what we are validating next, and here is the evidence we expect in the next two quarters. That sequence is more fundable than a five-year projection.
Stress-test your narrative against your metrics before investors do.
Before any fundraising conversation, ask whether every claim in the investor narrative has a corresponding data point proving the underlying economics are viable. Where the answer is no, that gap is exactly where scrutiny will concentrate. Closing those gaps through execution rather than explanation is what building the fundability bridge actually looks like.
Define and ground your capital ask before you enter the room.
The capital ask is not a transactional detail appended to the evidence chain — it is the logical conclusion of it. A company that can state precisely how much it is seeking, how those funds will be deployed against specific operational milestones, and what proof points the funding is expected to produce within the funding window demonstrates a level of strategic clarity that a vague or unanchored ask does not. Investors notice the absence of this specificity as readily as they notice gaps in the metrics. The ask itself is evidence — of how clearly the leadership team understands its own model, its next stage of growth, and the distance between where it is and where the capital will take it.
The Governance Dimension
For boards and advisors, the fundability bridge reframes the oversight role. The governing question is no longer “Is this company growing?” It is “Are we building the evidence chain that will allow investors to believe in this growth without requiring us to explain it?” This applies equally in PE and M&A contexts, where diligence teams apply the same evidence chain logic to margin visibility, recurring cash flow, and integration readiness — the vocabulary changes, but the underlying discipline is identical. Boards that demand this reporting infrastructure consistently position their companies to raise capital with confidence rather than scrambling to translate operational performance into investor language at the moment of need.
The macro context makes this discipline more urgent, not less. According to Bain’s 2026 Global Private Equity Report, buyout dry powder alone stood at approximately $1.3 trillion heading into 2026, with Preqin estimating total private capital dry powder across all strategies — spanning private equity, venture, real estate, infrastructure, and private credit — at approximately $3.7 trillion. That capital exists, is actively seeking deployment, and is concentrating around companies that meet increasingly high standards for evidence quality. The Harvard Business School research on venture decision-making confirms that execution credibility and team quality are primary drivers of investor conviction — not market size, not product sophistication, and not narrative elegance. The constraint has never been capital availability. It has always been the standard of evidence required to access it.
The Bridge Is the Business
The companies that consistently raise capital on their terms have stopped treating fundraising as a separate discipline. They have built their operations and their reporting to produce investor-legible evidence as a natural output of running the business well. The fundability bridge is not a pitch, a narrative, or a deck. It is a business that has earned the right to be believed — and can prove it, systematically, without the founder in the room. The fundability gap describes the problem. The fundability bridge is the answer. And the only way to build it is to start before you need it.
Has your company built the evidence chain — or are you still constructing the bridge on the way to the meeting?
References
- Harvard Business School / NBER – Gompers, Gornall, Kaplan & Strebulaev, How Do Venture Capitalists Make Decisions?
- PitchBook / NVCA – Venture Monitor Reports (2025–2026)
- Crunchbase – Global Venture Funding Trends & AI Investment Analysis (2025–2026)
- McKinsey & Company – The State of AI Report (2024–2025)
- Bain & Company – Global Private Equity Report (2025)
- Klaviyo S-1 Filing — U.S. Securities and Exchange Commission (2023)
- Convoy — Company Closure Coverage, The Wall Street Journal (2023)
- U.S. Securities and Exchange Commission — SEC Charges Two Investment Advisers with Making False and Misleading Statements About Their Use of Artificial Intelligence (2024)
- Moderna — S-1 Filing, U.S. Securities and Exchange Commission (2018)
- U.S. Securities and Exchange Commission — SEC v. Theranos, Elizabeth Holmes, and Ramesh Balwani (2018)
- WeWork — S-1 Filing and IPO Withdrawal Coverage, The Wall Street Journal (2019)
#VentureCapital #PrivateEquity #FamilyOffice #CapitalRaising #InvestorRelations
About the Author
Tom Krutilek is a Board Advisor and Chief Marketing Officer who works with early-stage and growth-stage companies on capital readiness, investor narrative, go-to-market strategy, and AI strategy and governance. His work focuses on a central question: whether growth is truly investable—not just impressive on paper.
He helps founders, CEOs, and boards connect commercial performance, capital strategy, and execution to the evidence investors need to underwrite growth. That includes strengthening the investor narrative, identifying gaps in capital readiness, building measurable growth systems, and evaluating where AI can create durable business value and competitive advantage.
Tom is also the founder of The Investor Narrative, a publication focused on private capital markets from the perspective of investor readiness. It examines the questions behind the headline numbers—how investors assess growth, capital efficiency, demand quality, competitive advantage, governance, and the assumptions that ultimately determine whether a company is ready for investment capital.